Universal Influenza Vaccine Technology Landscape

The Landscape is a database of novel vaccine candidates designed to provide broader and more durable protection against circulating and pandemic influenza viruses, compared with current strain-specific seasonal influenza vaccines. CIDRAP is developing the landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development.

Tracker

Vaccine Candidates 189 Vaccine Candidates
Vaccine in clinical trials 38 Vaccines in Clinical Trials
COVID+Flu Vaccine Candidates 4 COVID+Flu Vaccine Candidates
Developers 151 Developers
Platforms 6 Platforms
Preclinical 151
Phase 1 24
Phase 2 9
Phase 3 5
Approved 0

Database

Previous Next
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Platform

Influenza virus-based

13
Vaccines in
Preclinical
3
Vaccines in
Phase 1
2
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Nucleic acid-based

21
Vaccines in
Preclinical
11
Vaccines in
Phase 1
1
Vaccines in
Phase 2
2
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Non-VLP nanoparticles

34
Vaccines in
Preclinical
4
Vaccines in
Phase 1
2
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Recombinant proteins

36
Vaccines in
Preclinical
2
Vaccines in
Phase 1
1
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved